Looks like you’re on the US site. Choose another location to see content specific to your location

Home Industry News Pharmaceutical Caidya Secures $165 Million Investment from Rubicon Founders
pharma

Caidya Secures $165 Million Investment from Rubicon Founders

15th January 2025

Caidya, a prominent global clinical research organization (CRO), has announced a strategic growth investment of $165 million from Rubicon Founders. This substantial investment marks a significant milestone for Caidya, fostering organic expansion and exploring strategic acquisitions.

The collaboration brings together Caidya’s robust expertise in clinical research with Rubicon’s deep-rooted investment and operational experience in the healthcare sector. This partnership is likely to significantly impact the global biopharmaceutical landscape by advancing drug development and delivery of novel therapies.

With operations spanning 23 countries, Caidya is dedicated to innovating healthcare by supporting biopharmaceutical sponsors in bringing groundbreaking therapies to patients. The company’s extensive experience in oncology, hematology, and rare and pediatric diseases underscores its pivotal role in addressing unmet medical needs.

Supported by a network of global investors and now, Rubicon Founders, Caidya is well-positioned to enhance its service offerings and drive future growth. Rubicon Founders is renowned for its strategic approach to healthcare investments, emphasizing patient and doctor care. David M. Glaccum, partner at Rubicon, joining Caidya’s board, is indicative of the hands-on partnership between these entities.

The $165 million investment from Rubicon Founders is a testament to Caidya’s leading role in the clinical research sector. As Caidya continues its mission to innovate and provide access to advanced therapies globally, this partnership is expected to amplify their service capabilities and accelerate growth. This development not only bolsters Caidya’s market position but also promises significant advancements in healthcare delivery worldwide.

For the latest updates and in-depth insights into the world of Pharmaceuticals, including breakthrough treatments, industry trends, and regulatory news, contact Marcus Chalk today!

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.